GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong · Delayed Price · Currency is HKD 33.00
+3.42 (11.56%)
Sep 30, 2026, 4:08 PM HKT
HKG:2595 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 569.06 | 1,197 | 362.13 | 332.2 |
Short-Term Investments | 1,215 | 877.22 | 32.79 | - |
Trading Asset Securities | 5.26 | 0.02 | - | - |
Cash & Short-Term Investments | 1,790 | 2,075 | 394.92 | 332.2 |
Cash Growth | 388.31% | 425.35% | 18.88% | - |
Accounts Receivable | 14.54 | 15.92 | 109.15 | 72.35 |
Other Receivables | 45.48 | 33.21 | 26.14 | 10.01 |
Receivables | 60.02 | 49.13 | 135.29 | 82.36 |
Inventory | 1 | 17.34 | 5.59 | 2.06 |
Other Current Assets | 54.14 | 20.34 | 32.46 | 34.13 |
Total Current Assets | 1,905 | 2,161 | 568.25 | 450.74 |
Property, Plant & Equipment | 19.92 | 21.77 | 27.74 | 43.96 |
Long-Term Investments | - | - | - | 31.75 |
Other Intangible Assets | 2.61 | 1.08 | 1.26 | 1.4 |
Other Long-Term Assets | 12.72 | 11.26 | 9.58 | 8.28 |
Total Assets | 1,940 | 2,196 | 606.82 | 536.13 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 10.2 | 24.13 | 6.29 | 8.36 |
Accrued Expenses | 109.45 | 130.96 | 93.62 | 73.99 |
Short-Term Debt | 124.45 | 83.9 | 51.13 | 5.31 |
Current Portion of Leases | 5.99 | 5.5 | 4.24 | 5.53 |
Current Unearned Revenue | 17.96 | 18.18 | 42.2 | 101.91 |
Other Current Liabilities | 57.68 | 106.83 | 2,296 | 1,637 |
Total Current Liabilities | 325.72 | 369.49 | 2,493 | 1,832 |
Long-Term Leases | 8.36 | 11.52 | 13.98 | 20.84 |
Long-Term Unearned Revenue | - | - | - | 0.5 |
Other Long-Term Liabilities | - | - | 55.68 | - |
Total Liabilities | 334.07 | 381.01 | 2,563 | 1,853 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 37.04 | 37.04 | 26.77 | 22.03 |
Additional Paid-In Capital | 4,785 | 4,785 | 714.85 | 1,246 |
Retained Earnings | -3,317 | -3,097 | -1,303 | -1,359 |
Comprehensive Income & Other | 101.99 | 90.3 | -1,395 | -1,226 |
Shareholders' Equity | 1,606 | 1,815 | -1,956 | -1,317 |
Total Liabilities & Equity | 1,940 | 2,196 | 606.82 | 536.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 138.8 | 100.92 | 69.35 | 31.67 |
Net Cash (Debt) | 1,651 | 1,974 | 325.57 | 300.52 |
Net Cash Growth | 508.60% | 506.26% | 8.33% | - |
Net Cash Per Share | 3.53 | 6.67 | 1.26 | 1.36 |
Filing Date Shares Outstanding | 370.37 | 661.41 | 267.74 | 220.27 |
Total Common Shares Outstanding | 370.37 | 661.41 | 267.74 | 220.27 |
Working Capital | 1,579 | 1,792 | -1,925 | -1,381 |
Book Value Per Share | 4.34 | 2.74 | -7.31 | -5.98 |
Tangible Book Value | 1,603 | 1,814 | -1,958 | -1,319 |
Tangible Book Value Per Share | 4.33 | 2.74 | -7.31 | -5.99 |
Machinery | - | 46.11 | 46.08 | 46.19 |
Leasehold Improvements | - | 13.52 | 13.52 | 12.99 |